Edward S. Kim, MD, MBA, FACP, FASCO

Healio | HemOnc Today is excited to announce the nominees for its annual Disruptive Innovators Awards in oncology and hematology.

CHICAGO — In this Healio video exclusive, experts discussed the significance of men in leadership positions to be an ally to women in medicine.

Oncologists are trained to notice signs others miss. A cough. A patch of rough skin. A feeling of fatigue. However, there is one concern that is often unnoticed by men within our own profession: Gender discrimination.

Healio | HemOnc Today is excited to announce the nominees for its second annual Disruptive Innovators Awards in oncology and hematology.

Exposure to increased concentrations of airborne particulate matter appeared associated with increased risk for EGFR-mutated non-small cell lung cancer among never-smokers, according to study results presented at ESMO Congress.

Before the opening of City of Hope’s new comprehensive cancer center, many residents of Orange County, California, faced a long commute for advanced cancer care.

Considerably fewer community oncology clinicians than academic clinicians use biomarker testing to guide discussions with patients with lung cancer, according to survey results.

Enrollment in lung cancer clinical trials declined by more than 40% amid the COVID-19 pandemic, according to results of a global survey presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer.

In this episode, Edward S. Kim, MD, MBA, discusses his path to oncology, how he views disruption in health care, and the ways he’s innovating to help both patients and providers.

The addition of tislelizumab to chemotherapy led to improvements in PFS among patients with advanced squamous cell non-small cell lung cancer, according to results of the randomized phase 3 study published in JAMA Oncology.